JAMA Network Open Submission Guide

Official JAMA Network pages and official guidance explain scope, leadership, timing, APCs, open-access licensing, and submission mechanics. They do not tell authors whether their manuscript reads as broad general medical research, whether the JAMA-family routing is right, or whether the APC and publication-speed tradeoff makes sense for the author's specific paper.

This guide focuses on the pre-upload judgment: whether the study has enough clinical or health-system breadth for JAMA Network Open, whether a specialty JAMA journal would produce a stronger editorial read, and whether the abstract makes the patient, policy, or practice consequence visible before the methods detail.

For a broader check of the manuscript before choosing a JAMA-family route, use the Manusights AI manuscript review and compare the feedback against JAMA Network Open, JAMA, and the relevant specialty journal.

Source: JAMA Network Open for Authors, accessed May 2026.

Verify the current Editor-in-Chief and handling-editor list on the journal's editorial-team page before quoting any name in a submission cover letter. Use the journal-specific submission portal at JAMA Network Open manuscript system after confirming article type, reporting checklist, APC path, and JAMA-family routing.

This is the JAMA Network Open-specific structural detail authors most often miss:

JAMA Network Open is open access: all articles are immediately available at publication under an open-access license, and accepted research articles require article processing charge payment.

The OA model distinguishes the journal from subscription-based JAMA and many JAMA specialty routes. Authors should plan APC funding or waiver eligibility before submission. The official author page notes waivers and discounts for eligible authors from Hinari Core Offer countries.

The strategic implication: top-tier specialty work fits the relevant JAMA specialty journal; broader clinical research with OA preference fits JAMA Network Open; top general-medicine work fits JAMA itself.

Three operational signals govern editorial assessment:

This is what editors check before review: whether the manuscript is research that fits medicine or health, whether the article type matches JAMA Network Open rules, whether the structured abstract and Key Points make the clinical or policy consequence visible, and whether reporting standards are complete enough to survive peer review.

1. Clinical and health-research substance. JAMA Network Open requires substantive clinical or health-research contribution.

2. Methodological rigor. Clinical trials require CONSORT compliance; observational studies require STROBE; systematic reviews require PRISMA.

3. Reporting transparency. All studies require pre-registration where applicable and complete reporting per JAMA Network standards.

Editors specifically screen for whether the paper belongs in an open-access general medical journal rather than a specialty journal. In Manusights reviews, we find that manuscripts with excellent specialty methods still struggle when the abstract does not make the broader clinical-care, health-policy, or global-health consequence explicit.

Before submitting to JAMA Network Open, a JAMA Network Open manuscript fit check identifies whether the package meets the editorial bar before you commit to the submission.

Recent JAMA Network Open issues span:

• AI in clinical medicine (large language models, imaging AI)

• COVID-19 long-term effects and post-acute sequelae

• Cardiovascular epidemiology and outcomes

• Cancer screening and outcomes research

• Mental health treatment and outcomes

• Health disparities and equity research

• Comparative effectiveness research

• Maternal and child health

For specific recent papers and DOIs, see JAMA Network Open. The important editorial signal is breadth: the paper should speak to clinicians, investigators, policy makers, or public-health leaders beyond one narrow clinic or lab audience.

JAMA Network Open publishes its medians openly: 2 days to first decision without external review, 49 days with review, 92 days submission-to-acceptance. Treat these as planning ranges, not promises.

• Day 0: Manuscripts upload. The Manuscripts source page portal accepts the package, runs ICMJE and integrity checks, and assigns a handling editor.

• Days 1 to 2: Editorial admin and first read. The editor evaluates whether the manuscript fits an article type and meets reporting standards. The 2-day-median decision without external review lands here.

• Days 2 to 14: Initial decision. Roughly half of submissions are returned at this stage (out-of-scope, reporting-standard non-compliance, weak clinical signal). Papers that pass enter reviewer search.

• Days 14 to 49: Peer review and first decision. Reviewers return reports on a 4 to 6 week cadence; JAMA Network Open typically invites 2 to 3 reviewers. The 49-day-median first decision with review lands here.

• Days 49 to 92: Revision rounds and acceptance. Major revision is the most common outcome for papers that pass peer review. The 92-day median submission-to-acceptance assumes one revision round.

• Days 92 to 155: Acceptance to online publication. Production typically pushes papers online within 63 days of acceptance, with new content posted weekdays.

The sources above define the mechanics; the harder question is whether this draft earns review. The review tells you whether your paper clears the JAMA Network Open fit check before upload, especially around specialty-bound clinical implication hidden in the abstract behind methodology language, reporting-standards non-compliance (CONSORT/STROBE/PRISMA/STARD) on the relevant article type, and wrong JAMA-family venue chosen (JAMA / JAMA specialty / JAMA Network Open routing). Paid Manusights reviews include a 60-day money-back guarantee, and we do not train models on submitted manuscripts.

Across clinical-research manuscripts targeting JAMA Network Open, three recurring decision risks matter most across submissions that JAMA Network Open editors filter out at the desk-screen stage. (Per JAMA Network editorial policy, JAMA Network Open's 2-day median first decision without external review reflects fast desk-screening; the 49-day median with review and 12% acceptance rate mean ~88% of submissions don't survive to publication, primarily for breadth-of-clinical-relevance failures rather than methodological gaps.) Use the three checks below before you open JAMA Network manuscript portal upload slot.

A Manusights review checks whether your paper clears the JAMA Network Open-specific readiness checks that official instructions cannot evaluate from a generic JAMA Network checklist. Paid Manusights reviews include a 60-day money-back guarantee; submitted manuscripts are not used for model training.

Specialty-bound clinical implication hidden in the abstract behind methodology language

Across JAMA Network Open-targeted manuscripts, we consistently see authors write abstracts where the clinical implication is buried under methodology-first framing ("We conducted a multicenter retrospective cohort study using machine learning to predict X") rather than leading with the general-medical consequence ("Our findings suggest [X clinical decision] should change for the specific patient population across [setting types]").

JAMA Network Open editors specifically screen the abstract's Key Points + first two sentences to assess whether a non-specialist clinician, public-health investigator, or policy maker can immediately see why the result matters beyond one narrow clinical specialty.

Manuscripts where the clinical implication requires specialist context to interpret (e.g., the abstract assumes the reader knows the relevant subspecialty guideline, or the Key Points reference a single disease state without broader generalization) get redirected to JAMA, the relevant JAMA specialty journal, or returned to authors with the suggestion to reframe.

The fix is to rewrite the Key Points so each one names the clinical decision a non-specialist would make differently, restructure the abstract's Background and Conclusions to lead with the broader medical consequence, and explicitly identify in the cover letter the cross-specialty clinical audience the work speaks to.

Check whether your JAMA Network Open abstract makes the broad clinical consequence visible →

Reporting-standards non-compliance (CONSORT/STROBE/PRISMA/STARD) on the relevant article type

We frequently see JAMA Network Open manuscripts arrive without complete reporting-standards compliance for the article type, which the JAMA Network manuscript portal flags before the paper reaches the editor.

The journal requires CONSORT 2010 (randomized trials), STROBE (observational studies), PRISMA 2020 (systematic reviews), STARD 2015 (diagnostic accuracy studies), SRQR (qualitative research), TRIPOD+AI (prediction models), and SQUIRE (quality improvement) checklists as supplementary submission items with item-by-item page-number references.

Manuscripts that submit the checklist as a generic "compliant" attestation without specific page references, or omit the relevant checklist entirely for an applicable study type, face automated portal flags or editor returns.

The fix is to download the relevant EQUATOR Network checklist, complete it with page-number references to the manuscript, attach as a supplementary submission item, and verify the cover letter explicitly names which reporting standard was followed.

Check whether your JAMA Network Open reporting checklist package is complete →

Wrong JAMA-family venue chosen (JAMA / JAMA specialty / JAMA Network Open routing)

The third recurring pattern in JAMA Network Open-targeted manuscripts is contributions that fit a JAMA specialty journal (JAMA Oncology, JAMA Cardiology, JAMA Psychiatry, JAMA Neurology, JAMA Internal Medicine, JAMA Pediatrics, JAMA Dermatology, etc.) or JAMA itself but submitted to JAMA Network Open because of OA-preference or faster-decision logic.

JAMA specialty journals publish field-defining work within one specialty; JAMA publishes broadly practice-changing work across general medicine; JAMA Network Open publishes substantive clinical research with cross-specialty relevance preferring immediate open access (APC ~$3,000 per JAMA Network Open published fee schedule).

Manuscripts that are really JAMA specialty submissions get redirected with the recommendation to submit to the appropriate specialty journal first; manuscripts that are really JAMA submissions get redirected upward.

The fix is to read 5 recent papers from JAMA Network Open, 5 from the candidate JAMA specialty journal, and 5 from JAMA itself, identify which editorial direction matches the contribution's breadth and clinical-decision impact, and write the cover letter explicitly explaining why JAMA Network Open is the right home (not just the OA-required venue or fastest-decision target).

Check whether JAMA Network Open is the right JAMA-family route for your manuscript →

Check whether your JAMA Network Open manuscript is submission-ready →

• Is JAMA Network Open a good journal?

• JAMA Network Open journal profile

• JAMA Submission Guide

• BMJ Submission Guide

While the manuscript is in peer review, use the companion JAMA Network Open Under Review status guide to interpret portal movement, follow-up timing, and reviewer-risk preparation without confusing the status page with the submission guide.